Panjon Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.73 Cr
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 14.07 Cr
About Panjon Pharma
Panjon Pharma Limited (PPL) is a Public Limited Indian Non-Government Company incorporated in India on 12 October 1994 and has a history of 30 years and four months. Its registered office is in Indore, Madhya Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.73 Cr.
The company currently has active open charges totaling ₹14.07 Cr.
Manoj Kothari, Anju Kothari, and Kirti Shah serve as directors at the Company.
Company Details
- Location Indore, Madhya Pradesh
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232MP1994PLC008714
-
Company No.
008714
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
12 Oct 1994
-
Date of AGM
30 Sep 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Panjon Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Kothari
|
Managing Director | 12-Oct-1994 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Anju Kothari
|
Director | 12-May-1999 | Current |
|
Kirti Shah
|
Director | 18-Jul-2002 | Current |
Financial Performance of Panjon Pharma.
Enhance accessibility to Panjon Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panjon Pharma?
Unlock access to Panjon Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹14.07 Cr
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 11.60 Cr
- State Bank Of India : 2.00 Cr
- Icici Bank Limited : 0.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2007 | Icici Bank Limited | ₹4.72 M | Open |
| 31 Jan 2007 | Punjab National Bank | ₹5.60 Cr | Open |
| 17 Dec 2004 | State Bank Of India | ₹2.00 Cr | Open |
| 04 Jun 2003 | Punjab National Bank | ₹4.50 Cr | Open |
| 04 Jun 2003 | Punjab National Bank | ₹1.50 Cr | Open |
How Many Employees Work at Panjon Pharma?
Unlock and access historical data on people associated with Panjon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panjon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panjon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.